Related Experiment Video
Updated: Jul 30, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Validation Rules as a First Step for Data Quality: Pharmacovigilance Application in Portugal
Bárbara Costa1,2, Bruno Figueiredo2, Vera Pinheiro1,2,3
1CINTESIS, Faculty of Medicine, University of Porto, Portugal.
Improving patient safety through better tracking of Adverse Drug Reactions (ADRs) is vital. This study enhances the SIRAI application in Portugal with data validation rules and a scoring system to boost ADR monitoring effectiveness.
Area of Science:
- Pharmacovigilance and Drug Safety
- Health Informatics
- Data Quality Management
Background:
- Effective tracking and reporting of Adverse Drug Reactions (ADRs) are essential for safeguarding patient health.
- The SIRAI application in Portugal plays a key role in monitoring these events.
- Ensuring high data quality within pharmacovigilance systems is a recognized challenge.
Purpose of the Study:
- To enhance the data quality of the SIRAI application used for ADR reporting in Portugal.
- To develop and implement robust data validation rules.
- To create a scoring system for assessing individual records and the overall dataset quality.
Main Methods:
- Development of a comprehensive set of data validation rules tailored to ADR reporting.
- Implementation of a scoring mechanism to evaluate the quality of each ADR record.
- Creation of an aggregate scoring system to assess the overall quality of the SIRAI dataset.
Main Results:
- The implemented data validation rules identified and flagged potential data quality issues.
- The scoring system provided a quantifiable measure of data integrity for individual records and the dataset.
- Preliminary analysis indicated an improvement in the overall data quality of the SIRAI application.
Conclusions:
- The developed data validation rules and scoring system are effective in improving ADR data quality.
- Enhanced data quality in the SIRAI application will lead to more reliable pharmacovigilance and improved patient safety.
- This approach provides a scalable model for quality improvement in other pharmacovigilance systems.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Data Validation
Key parameters for method validation include:
Drug Regulation
Quality Assurance
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

